X0508 4 2025-03-05 0001281895 ROCKET PHARMACEUTICALS, INC. RCKT 0001437590 Dolsten Mikael C/O ROCKET PHARMACEUTICALS, INC. 9 CEDARBROOK DRIVE CRANBURY NJ 08512 true false Common Stock 2025-03-05 4 J 0 14220 0 A 14220 D Represent restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will become fully vested on December 31, 2025. Rocket Pharmaceuticals, Inc. (the "Company") entered into a consulting agreement with the Reporting Person, effective March 3, 2025, for services related to the Company's research and development activities. As part of the compensation for services rendered, the Reporting Person received $125,000 of RSUs valued based on the closing price of the Company's common stock on March 3, 2025, which will cliff vest on December 31, 2025. /s/ Martin Wilson, as attorney-in-fact for Mikael Dolsten 2025-04-24